Lumentum Q4: Exceptional Component-Led Growth Pushes September EPS Guide to $4.20

What happened

Lumentum reported fiscal Q4 2026 results with year-over-year revenue up $525.6 million, driven by $329.0 million from Components and $196.6 million from Systems. The company guided September quarter EPS midpoint to $4.20, which is more than double the EPS earned in all of fiscal 2025. Holding that September revenue guide flat for four quarters implies fiscal 2027 revenue of $5.0 billion, up 66% from the just-closed fiscal year. The growth is coming primarily from chips rather than finished boxes, indicating a shift toward higher-volume optical components. However, the stock trades at extreme valuations and the prior deep-value report flagged unreliable backlog, lack of long-term customer commitments, and ASP pressure, so this blowout guide needs validation through actual contracted orders.

Implication

The $4.20 EPS guide for a single quarter materially exceeds the company's entire fiscal 2025 earnings, suggesting an unprecedented demand surge, but it also sets an extremely high bar that leaves no room for execution misses. The mix shift toward components is encouraging because it may carry higher margins and better scalability than systems, but it also exposes Lumentum to faster price erosion if competitors ramp capacity. The implied $5 billion fiscal 2027 revenue run-rate assumes zero sequential growth from the September guide for four quarters, which is an aggressive extrapolation given the company's own 10-Q language that backlog is not reliable and most customers lack long-term volume commitments. Valuation remains extreme: at the current price, the stock trades at 168x trailing earnings, so any revenue or margin disappointment would trigger severe multiple compression. Investors should monitor the next earnings call for evidence of contracted purchase commitments or take-or-pay terms; absent such evidence, the prudent approach is to wait for a pullback toward the previously identified $850 attractive entry rather than chase the momentum.

Thesis delta

The prior WAIT thesis was based on needing one more quarter to confirm durable AI demand. The new guidance strongly suggests that demand is not only durable but accelerating, pushing the stock into a more attractive fundamental trajectory. However, the lack of contractual commitments and the extreme valuation mean the risk-reward has not improved enough to warrant upgrading to a full buy; the thesis shifts from 'wait for confirmation' to 'wait for a better entry price while acknowledging the upside potential.'